Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12318207 | 1.00 | LMNA (0.41) | LMNAALDH1A1KDM4ECYP1A2TSHR | |
| SCHEMBL11243501 | 0.82 | LMNA (0.38) | LMNAALDH1A1 | |
| SCHEMBL11243489 | 0.82 | LMNA (0.38) | LMNAALDH1A1 | |
| SCHEMBL11243495 | 0.82 | LMNA (0.38) | LMNAALDH1A1 | |
| SCHEMBL359576 | 0.81 | LMNA (0.42) | LMNAALDH1A1CYP1A2TSHRCYP2C19 | |
| SCHEMBL1150726 | 0.81 | LMNA (0.42) | LMNAALDH1A1CYP1A2TSHRCYP2C19 | |
| SCHEMBL357507 | 0.81 | LMNA (0.42) | LMNAALDH1A1CYP1A2TSHRCYP2C19 | |
| SCHEMBL10509268 | 0.81 | LMNA (0.42) | LMNAALDH1A1CYP1A2TSHRCYP2C19 | |
| SCHEMBL10509277 | 0.81 | LMNA (0.42) | LMNAALDH1A1CYP1A2TSHRCYP2C19 | |
| SCHEMBL7643956 | 0.79 | LMNA (0.41) | LMNAALDH1A1CYP1A2TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202904-B2 | α-cyano-4-fluoro-3-phenoxybenzyl meta-halo pyrethrate, a process for preparing the same and the uses thereof | EAST CHINA NORMAL UNIVERSITY (CN) | 2012-06-19 | — | — | US | disclosed |
| US-20100286265-A1 | ALPHA-CYANO-4-FLUORO-3-PHENOXYBENZYL META-HALO PYRETHRATE, A PROCESS FOR PREPARING THE SAME AND THE USES THEREOF | EAST CHINA NORMAL UNIVERSITY (CN) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286265-A1 | ALPHA-CYANO-4-FLUORO-3-PHENOXYBENZYL META-HALO PYRETHRATE, A PROCESS FOR PREPARING THE SAME AND THE USES THEREOF | CYP8B1, CTRL, CBR3 | LMNA 1734/4885ALDH1A1 2989/4885KDM4E 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.